Never miss another update

Subscribe Today!

AlzeCure gets Late Breaking Abstract Accepted on NeuroRestore’s Positive Effect on Mitochondrial Function

STOCKHOLM, SWEDEN / ACCESSWIRE / January 11, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that an abstract on its… Read More »AlzeCure gets Late Breaking Abstract Accepted on NeuroRestore’s Positive Effect on Mitochondrial Function

The post AlzeCure gets Late Breaking Abstract Accepted on NeuroRestore’s Positive Effect on Mitochondrial Function appeared on Stocks News Feed.

Posted in

The Markets Today